DrugsControl Media Services

News Detail

Implementing corrective actions at Goa unit; stopped Digene production, says Abbott (15-09-2023)

Mumbai, 14 Sept 2023: Drug maker Abbott on September 14 said it is implementing corrective actions at its Goa-based facility from where it had produced antacid Digene Gel that was recalled from the market due to non-compliance with manufacturing norms. Earlier this month, regulat......
View Details

Source : PTI and Reuters
Abbott Digene FDA DCGI Drugs Controller General of India DCGI advisory for patients and healthcare professionals Digene gel Abbott voluntary recall

Related News